APEX Biologix Enters Into Agreement with Mayo Clinic

APEX Biologix entered into a know-how license agreement with Mayo Clinic to jointly develop new regenerative medicine products.

Under the agreement, Mayo Clinic will license its know-how to APEX Biologix, enabling the two organizations to collaborate on the development of new therapies that can potentially transform the treatment of...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us